ECB no longer accepts syndicated loans as collateral

On October 15, the ECB widened the framework of eligible collateral in an effort to facilitate access to its credit lines and boost liquidity among European banks. The Bank of England specifically excluded syndicated-loans in the range of collateral it would accept on its own credit schemes earlier last month.

Euro-dominated syndicated loans and various debt instruments would qualify under the new guidelines, while the ECB also enhanced its longer-term refinancing operations to help banks in an increasingly hostile credit environment.

However, the ECB ceased to accept syndicated loans as collateral for its credit lines on November 21, having only started to admit them on November 17. The collateral was originally intended to be eligible until the end of 2009.

The move has puzzled bankers and ratings agencies alike, particularly as the ECB is refusing to comment on why it no longer accepts the loans. One ratings agency analyst speculated the ECB may be concerned that a credit event on the loans would be out of their jurisdiction, which could cause them unnecessary problems.

"It's most mysterious," said one head of global credit strategy at a multinational bank. "You would have thought that somebody was, in their minds, abusing the system, and so they put a stop to it."

"But it could be something perfectly innocent like the ECB realised it would be difficult to price this stuff as syndicated loans never trade," he added.

An ECB official said that the bank believes it currently accepts a sufficient range of collateral to allow banks access to its liquidity schemes, begging the question why it decided to accept syndicated loans in the first place.

See also: Demand wanes for central bank liquidity schemes
Central banks promise unlimited dollar lending

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here